The two teamed up in 2007 to combine human pluripotent stem cell biology expertise from Gordon Keller, head of UHN's McEwen Centre for Regenerative Medicine in Toronto, with VistaGen's Human Clinical Trials in a Test Tube stem cell technology platform

Aldagen Inc., of Durham, N.C., published a paper in the Journal of Stem Cell Research & Therapy describing the mechanisms by which its cell therapy products promoted formation of new blood vessels in ischemic tissues

The firms inked the deal in 2006 to work on MultiStem, an adult stem cell-derived product for cardiovascular indications such as acute myocardial infarction

Mesoblast Ltd., of Melbourne, Australia, said preclinical data showed a single intravenous injection of its allogeneic adult stem cell product, Mesenchymal Precursor Cells, lowered blood sugar in animal models of Type II diabetes

Mesoblast Ltd., of Melbourne, Australia, received regulatory clearance from the Singapore Health Sciences Authority to begin the first Phase II trial of its allogeneic adult stem cell therapy for patients with neovascular (wet) age-related macular degeneration (AMD

Geron Corp., of Menlo Park, Calif., reported data on the use of GRNOPC1 , oligodendrocyte progenitors derived from human embryonic stem cells, for myelin repair in a non-human primate model

The company decided to examine the possibility of testing its cardiac stem cell treatment outside of the U.S...in light of the progress toward its trial of UMK-121, its stem cell treatment for patients awaiting liver transplant to overcome end-stage liver disease in the U.S. Conducting the trial offshore will help reduce costs, Proteonomix said

NeoStem Inc., of New York, closed its previously announced acquisition of privately held stem cell firm Amorcyte Inc., of Hackensack, N.J. (See BioWorld Today, July 18, 2011

Sangamo BioSciences Inc., of Richmond, Calif., said a preclinical study demonstrated the highly specific, functional correction of the alpha 1-antitrypsin gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases (ZFN

International Stem Cell Corp., of Carlsbad, Calif., completed preclinical studies of its human neuronal cells...The cells are derived from human parthenogenetic stem cells, and have relevance for a number of indications including Parkinson's disease

In return, Inspiration will issue a convertible note to Ipsen, bringing Ipsen's fully diluted equity ownership position in Inspiration to approximately 38 percent...Other Phase II results in ovarian and small-cell lung cancer showed long-term clinical benefit, and Phase I results established safety of a high dose level with two-hour infusion

TXA127, an angiotensin (1-7) peptide, previously gained orphan status as a treatment to enhance engraftment in patients receiving a stem cell transplant and as a treatment for myelodysplastic syndromes

VistaGen Therapeutics Inc., of South San Francisco, published preclinical data showing that pluripotent stem cells can be used to generate insulin in mice

Ltd., of Germantown, Md., said its scientists collaborated with Samsung Bioscience Research Institute of Samsung Medical Center in Seoul, Korea, on a preclinical study using fat-derived adult stem cells to treat systemic lupus erythematosus (SLE

The trial will evaluate tumor stem cell burden as a primary endpoint at the end of the trial

ReNeuron Ltd., of Guildford, UK, received clearance from an independent data safety monitoring board to advance to a higher dose of stem cell treatment ReN001 in its Phase I trial for stroke

BioTime Inc., of Alameda, Calif., entered an exclusive license and sponsored research agreement with Cornell University for the worldwide development and commercialization of technology for the differentiation of human embryonic stem cells into vascular endothelial cells

StemCells Inc., of Newark, Calif., said the California Institute of Regenerative Medicine approved the firm's application of a planning grant of $100.000, which will help fund the development of human neural stem cell product HuCNS-SC cells in Alzheimer's disease by enabling StemCells and its collaborators at the University of California, Irvine, to prepare and submit for a Disease Team Therapy Development Research Award, which could bring the firm up to $20 million over four years to support

NovaHep focuses on liver stem cells, while Recopharma focuses on recombinant glyco proteins...Although Allenex has been the sole financier of both companies to date, it said funding such developmental work is challenging in the current environment, and it needs to prioritize its own organ and stem cell transplantation business